| Phase separation of disease-associated SHP2 mutants underlies MAPK hyperactivation G Zhu, J Xie, W Kong, J Xie, Y Li, L Du, Q Zheng, L Sun, M Guan, H Li, ... Cell 183 (2), 490-502. e18, 2020 | 158 | 2020 |
| Structure-based peptide inhibitor design of amyloid-β aggregation J Lu, Q Cao, C Wang, J Zheng, F Luo, J Xie, Y Li, X Ma, L He, ... Frontiers in molecular neuroscience 12, 54, 2019 | 72 | 2019 |
| A novel partially open state of SHP2 points to a “multiple gear” regulation mechanism Y Tao, J Xie, Q Zhong, Y Wang, S Zhang, F Luo, F Wen, J Xie, J Zhao, ... Journal of Biological Chemistry 296, 2021 | 23 | 2021 |
| Nicotinamide mononucleotide adenylyltransferase uses its NAD+ substrate-binding site to chaperone phosphorylated Tau X Ma, Y Zhu, J Lu, J Xie, C Li, WS Shin, J Qiang, J Liu, S Dou, Y Xiao, ... elife 9, e51859, 2020 | 21 | 2020 |
| Non-ergodicity of a globular protein extending beyond its functional timescale J Li, JF Xie, A Godec, KR Weninger, C Liu, JC Smith, L Hong Chemical Science 13 (33), 9668-9677, 2022 | 8 | 2022 |
| Mechanistic insights into NAD synthase NMNAT chaperoning phosphorylated Tau from pathological aggregation X Ma, J Lu, Y Zhu, J Xie, C Li, A Shin, J Qiang, J Liu, S Dou, Y Xiao, ... bioRxiv, 800565, 2019 | | 2019 |
